Cell-Selective Binding Zwitterionic Polymeric Micelles Boost the Delivery Efficiency of Antibiotics

Huahai Yu,Ying Piao,Yifan Zhang,Jiajia Xiang,Shiqun Shao,Jianbin Tang,Zhuxian Zhou,Youqing Shen

DOI: https://doi.org/10.1021/acsnano.3c05181

IF: 17.1

2023-11-08

ACS Nano

Abstract:Effective accumulation and penetration of antibiotics in the biofilm are critical issues for bacterial infection treatment. Red blood cells (RBCs) have been widely utilized to hitchhike nanocarriers for drug delivery. It is vital and challenging to find a nanocarrier with an appropriate affinity toward RBCs and bacteria for selective hitchhiking and release that determines the drug delivery efficiency and specificity. Herein, we report a zwitterionic polymer...

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology

What problem does this paper attempt to address?

The key problem that this paper attempts to solve is how to improve the effective accumulation of antibiotics at the infection site and the ability to penetrate biofilms, so as to improve the treatment effect of bacterial infections. Specifically, the researchers developed a micellar system based on the zwitterionic polymer poly(2-(N - oxide - N,N - diethylamino)ethyl methacrylate) (OPDEA), aiming to improve the delivery efficiency of antibiotics by selectively hitchhiking on red blood cells (RBCs) and preferentially releasing them at the infection site.

### Research Background and Challenges

1. **Antibiotic Delivery Difficulties**:
- Current delivery systems can only deliver a small amount of antibiotics to the infection site, and most of them are unable to effectively penetrate biofilms, resulting in poor clinical efficacy.
- For example, micelles with a polyethylene glycol (PEG) hydrophilic shell can achieve long - term blood circulation, but cannot effectively accumulate and penetrate the infection site.
- Although cationic nanoparticles have good penetration and retention properties, they will be quickly recognized and cleared by the host immune system in the blood.

2. **Advantages of Red Blood Cells as Carriers**:
- Red blood cells are naturally involved in the transport of oxygen and carbon dioxide and have been used to develop drug delivery systems.
- Ideally, nanoparticles should be able to non - covalently adsorb on red blood cells and specifically detach when reaching the infection site, thereby prolonging blood circulation time and increasing drug accumulation.

### Solutions

The researchers designed OPDEA - based micelles, which can:
- **Selectively Bind to Red Blood Cells**: Bind to the red blood cell membrane through phospholipid - related affinity.
- **Preferentially Release at the Infection Site**: Due to the stronger interaction with the cell wall of Gram - positive bacteria, they can quickly transfer and release at the infection site.
- **Penetrate Biofilms**: The zwitterionic surface and cell wall affinity promote their penetration in biofilms.

### Experimental Verification

1. **Selective Binding Experiment**:
- The adsorption capacity of OPDEA micelles to Gram - positive bacteria (such as methicillin - resistant Staphylococcus aureus (MRSA)) is 4 - 6 times stronger than that to Gram - negative bacteria.
- OPDEA micelles are mainly adsorbed on the cell wall of Gram - positive bacteria, rather than inside the cells.

2. **Transfer from Red Blood Cells to Bacteria**:
- OPDEA micelles can transfer from red blood cells to MRSA, while the transfer to the Gram - negative bacterium PST is less, verifying its selectivity for Gram - positive bacteria.

3. **Biofilm Penetration Ability**:
- The penetration depth of OPDEA micelles in biofilms is 5 - 6 times that of PEG micelles, and the total fluorescence intensity is 3 - 4 times that of PEG micelles.

4. **In Vivo Antibacterial Effect**:
- In peritonitis and pneumonia models, OPDEA/Clarith micelles showed significantly enhanced drug accumulation and antibacterial effects.

### Conclusion

This study shows that the OPDEA - based nanocarrier improves drug delivery efficiency and specificity by selectively binding to red blood cells and preferentially releasing antibiotics at the infection site, providing a promising strategy for designing new antibacterial nanomedicines.